Highbridge Capital Management LLC Bristol Myers Squibb CO Call Options Transaction History

Highbridge Capital Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $4.46 Million - $4.93 Million	-100,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $4.34 Million - $5.18 Million	96,200 Added 2531.58%	100,000 $4.77 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $9.91 Million - $12.4 Million	-196,200 Reduced 98.1%	3,800 $211,000
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $27.6 Million - $31.9 Million	-500,000 Reduced 71.43%	200,000 $12.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	700,000	700,000 $39 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.